Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Business Currents.
Press releases published on June 23, 2025
Small Drones Market Size Expected to Reach $24.29 Billion by 2030
EIN Presswire
·
June 23, 2025
Global small drones market was valued at $7.44 billion in 2020, and is projected to reach $24.29 billion by 2030, registering a CAGR of 13.16%. WILMINGTON, DE, UNITED STATES, June 23, 2025 /EINPresswire.com/ -- Increased operational efficiency and surge …
Aerial Imaging Market Size Expected to Reach $8.52 Billion by 2030
EIN Presswire
·
June 23, 2025
Global aerial imaging market was valued at $2.26 billion in 2020, and is projected to reach $8.52 billion by 2030, registering a CAGR of 14.2%. WILMINGTON, DE, UNITED STATES, June 23, 2025 /EINPresswire.com/ -- By application, the geospatial mapping …
UMH PROPERTIES, INC. WILL HOST SECOND QUARTER 2025 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL
GlobeNewswire
·
June 23, 2025
FREEHOLD, NJ, June 23, 2025 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE: UMH) (TASE: UMH), a real estate investment trust (REIT) specializing in manufactured home communities, announced that it will host its Second Quarter 2025 Financial Results Webcast …
ZOOZ Power Explores Strategic Opportunities as Leading Defense Company Commences POC for Flywheel-Based Power Booster
GlobeNewswire
·
June 23, 2025
Board of Directors Announces Restructuring Plan Tel Aviv, Israel, June 23, 2025 (GLOBE NEWSWIRE) -- ZOOZ Power (Nasdaq and TASE: ZOOZ), a leading provider of flywheel-based power boosters and energy management systems for enabling ultra-fast EV charging …
Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress
GlobeNewswire
·
June 23, 2025
REHOVOT, Israel, June 23, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …
Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine
GlobeNewswire
·
June 23, 2025
Final analysis of PEARL real world migraine prevention study presented at 11th Congress of the European Academy of Neurology (EAN 2025) Congress in Helsinki1,2 Fremanezumab demonstrated sustained effectiveness and a favourable safety and tolerability …